List your practice on InjuredCare | Log in / Sign up



Aciphex is in the class of drugs known as proton-pump inhibitors (PPIs). PPIs work to slow down the body's production of stomach acid over a sustained period of time, helping patients with chronic or acute reflux and stomach issues.

Initially approved by the FDA in 1999, Aciphex is manufactured by Eisai, Inc., and is referred to as Pariet outside the US. Aciphex is prescribed for the maintenance and/ or treatment of ulcerative or erosive gastroesophageal reflux disease (GERD), duodenal ulcers, and pathological hypersecretory conditions.

While many PPIs are considered safe, numerous studies have linked long-term (more than one year) PPI use with serious side-effects, especially kidney malfunction.

Severe Side Effects of Aciphex

Numerous studies have examined the efficacy and safety of PPIs like Aciphex in recent years. These studies have connected regular Aciphex use to serious adverse health events.

In 2010 the FDA warning of an increased risk of bone fractures with regular PPI use.

Late in 2014, the FDA updated Aciphex's label to include a stronger warning of acute interstitial nephritis. This label change was corroborated by two separate studies released in 2015 and 2016. The 2015 study, published in the Canadian Medical Association Journal, found a 2.5x increase in instances of acute kidney injury among PPI users and a 3x increase in nephritis. A 2016 study at Johns Hopkins University found a 20-50% increase in chronic kidney disease for people taking PPIs over the control group.

Another study published in the Journal of the American Society of Nephrology in 2016 showed a 96% increase in kidney failure with PPI use over alternate heartburn treatments (H2-blockers). Affirming the findings from the Johns Hopkins study, this JASN study found a 26% increase in chronic kidney disease.

A 2017 study published in the peer-reviewed medical journal Gut found a 2x increased likelihood of stomach cancer for regular Aciphex takers.

Severe side-effects linked to Aciphex include:

  • Acute interstitial nephritis (renal lesion)
  • Hypomagnesemia
  • Bone fracture (primarily in hips, wrists, and spine)
  • New or worsening lupus symptoms
  • Cyanocobalamin
  • Stomach cancer

Related Articles

  • Avandia


    The Trade Name for the Diabetes Drug Rosiglitazone Avandia is a prescription drug, patented in 1987 and approved by the Food and Drug Administration (FDA) for use in the United St Read More...

  • Alli


    Alli, a drug with the active ingredient orlistat, was first introduced into U.S. markets in 1999 under the brand name Xenical as a prescription weight-loss medication. Alli was app Read More...

  • Actos


    Actos (pioglitazone) is manufactured by Takeda Pharmaceuticals and was approved by the FDA July 15, 1999, for the treatment of Type-2 diabetes. Marketed by Eli Lilly in the U.S., A Read More...

© 2015-2022 LawConnect, Inc. All rights reserved.